2015
Overview
Medulloblastoma is a type of brain tumor that is commonly found in children. It is a highly malignant cancer that originates in the cerebellar region of the brain. The cerebellum is the part of the brain that controls movement and coordination, so the presence of a tumor in this area can cause significant problems. Medulloblastoma is a rare and difficult-to-treat cancer, and it can be challenging to diagnose as well. It is often misdiagnosed as another type of brain tumor or neurological condition. The symptoms of medulloblastoma can include headaches, nausea, vomiting, difficulty with coordination or balance, and behavioral changes. Recent research in hematology and oncology has revealed many promising new treatments for medulloblastoma. For example, targeted therapies that focus on the specific genetic mutations that cause the cancer have shown great promise in clinical trials. Immunotherapies that harness the power of the patient's own immune system to fight the cancer are also being developed. Despite these advances, treating medulloblastoma remains a challenge. Surgery, radiation therapy, and chemotherapy are still the primary treatment options for this cancer, and they can have significant side effects. Ongoing research is critical to finding new and better ways to treat medulloblastoma and improve the prognosis for children with this devastating disease.
Research published in this journal
1 peer-reviewed article, ranked by relevance. Each links to its DOI.
How this research is being cited
The 1 article above has been cited 1 time in the scholarly literature. Citation data via OpenAlex and Crossref, updated Jun 2026.
-
T. Gupta et al. · 2018 · International Journal of Neurooncology
A sample of recent works citing this journal's research on Medulloblastoma, linking to each citing work.